Research

From 'Specific-Solution' to 'Systemic-Solution' Paradigm

CVIVA aims to end the current 'specific-solution' paradigm, i.e. vaccines and micronutrients protect only against the targeted diseases and deficiencies.

CVIVA will establish a new 'systemic-effect' paradigm by documenting that the immune system is a learning entity, which differs for males and females, and which may be stimulated beneficially or deleteriously by vaccines and micronutrients.

 

 

 

 

 

 

 

 

 

 

Last revised 10 April 2012

Contact CVIVA

Research Center for Vitamins and Vaccines
Bandim Health Project
Statens Serum Institut
5 Artillerivej
DK-2300 Copenhagen S 

Phone: 3268 8256
Email: